FE5
5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine
Find entries where: FE5
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine |
Identifiers | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine |
Formula | C15 H15 N7 O |
Molecular Weight | 309.326 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N |
InChI | InChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19) |
InChIKey | GYLDXIAOMVERTK-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 38 |
Chiral Atom Count | 0 |
Bond Count | 41 |
Aromatic Bond Count | 20 |
Drug Info: DrugBank
DrugBank ID | DB11836 |
---|---|
Name | Sapanisertib |
Groups | investigational |
Description | Sapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others. |
Synonyms |
|
Categories |
|
CAS number | 1224844-38-5 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3545097 |
PubChem | 45375953 |
ChEMBL | CHEMBL3545097 |
ChEBI | CHEBI:91450 |